Sally E. Stringer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sally E. Stringer has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Anjali Kalyani
1 shared publicationChristopher J. Robinson
The Cancer Research Campaign Department of Drug Development and the CRC and University of Manchester Department of Medical Oncology , Paterson Institute for Cancer Research, Christie Hospital, Manchester, M20 4BX, UK
1 shared publicationJohn T. Gallagher
1 shared publicationMahendra Rao
1 shared publicationMargot Mayer-Proschel
1 shared publication
Latest Publications
- Open Access
- 1 March 2001
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 114 (5) , 853-865
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
Vascular endothelial growth factor (VEGF) is a secreted mitogen highly specific for cultured endothelial cells. In vivo VEGF induces microvascular permeability and plays a central role in both angiogenesis and vasculogenesis. VEGF is a promising target for therapeutic intervention in certain pathological conditions that are angiogenesis dependent, most notably the neovascularisation of growing tumours. Through alternative mRNA splicing, a single gene gives rise to several distinct isoforms of VEGF, which differ in their expression patterns as well as their biochemical and biological properties. Two VEGF receptor tyrosine kinases (VEGFRs) have been identified, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). VEGFR-2 seems to mediate almost all observed endothelial cell responses to VEGF, whereas roles for VEGFR-1 are more elusive. VEGFR-1 might act predominantly as a ligand-binding molecule, sequestering VEGF from VEGFR-2 signalling. Several isoform-specific VEGF receptors exist that modulate VEGF activity. Neuropilin-1 acts as a co-receptor for VEGF165, enhancing its binding to VEGFR-2 and its bioactivity. Heparan sulphate proteoglycans (HSPGs), as well as binding certain VEGF isoforms, interact with both VEGFR-1 and VEGFR-2. HSPGs have a wide variety of functions, such as the ability to partially restore lost function to damaged VEGF165 and thereby prolonging its biological activity.
- 1 March 2001
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 114 (5) , 853-865
Open AccessThe splice variants of vascular endothelial growth factor (VEGF) and their receptors
Vascular endothelial growth factor (VEGF) is a secreted mitogen highly specific for cultured endothelial cells. In vivo VEGF induces microvascular permeability and plays a central role in both angiogenesis and vasculogenesis. VEGF is a promising target for therapeutic intervention in certain pathological conditions that are angiogenesis dependent, most notably the neovascularisation of growing tumours. Through alternative mRNA splicing, a single gene gives rise to several distinct isoforms of VEGF, which differ in their expression patterns as well as their biochemical and biological properties. Two VEGF receptor tyrosine kinases (VEGFRs) have been identified, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). VEGFR-2 seems to mediate almost all observed endothelial cell responses to VEGF, whereas roles for VEGFR-1 are more elusive. VEGFR-1 might act predominantly as a ligand-binding molecule, sequestering VEGF from VEGFR-2 signalling. Several isoform-specific VEGF receptors exist that modulate VEGF activity. Neuropilin-1 acts as a co-receptor for VEGF165, enhancing its binding to VEGFR-2 and its bioactivity. Heparan sulphate proteoglycans (HSPGs), as well as binding certain VEGF isoforms, interact with both VEGFR-1 and VEGFR-2. HSPGs have a wide variety of functions, such as the ability to partially restore lost function to damaged VEGF165 and thereby prolonging its biological activity.
- Open Access
- 1 September 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (36) , 25455-25460
Heparin Is a Unique Marker of Progenitors in the Glial Cell Lineage
- 1 September 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (36) , 25455-25460
Open AccessHeparin Is a Unique Marker of Progenitors in the Glial Cell Lineage